Acro Biomedical Co., Ltd. Stock Other OTC
Equities
ACBM
US0048921052
Food Processing
Sales 2021 | 1.2M 1.63M | Sales 2022 | 658K 896K | Capitalization | 270M 368M |
---|---|---|---|---|---|
Net income 2021 | -7M -9.52M | Net income 2022 | -15M -20.41M | EV / Sales 2021 | 233 x |
Net cash position 2021 | 24.08K 32.76K | Net Debt 2022 | 98.69K 134K | EV / Sales 2022 | 410 x |
P/E ratio 2021 |
-32.5
x | P/E ratio 2022 |
-17
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 50.03% |
Managers | Title | Age | Since |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 17-01-29 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 17-01-29 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
1st Jan change | Capi. | |
---|---|---|
+16.86% | 8.48B | |
+6.26% | 7.6B | |
+4.89% | 6.39B | |
-5.48% | 3.75B | |
-6.58% | 3.71B | |
-3.55% | 1.36B | |
-28.87% | 1.11B | |
+18.12% | 1.02B | |
-8.94% | 924M |